Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy (2015)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1016/j.ejca.2014.10.019
- Subjects: NEOPLASIAS COLORRETAIS (TERAPIA); FATORES DE CRESCIMENTO; QUIMIOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Cancer
- ISSN: 0959-8049
- Volume/Número/Paginação/Ano: v. 51, n. 1, p. 18-26, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
RUFF, Paul et al. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, v. 51, n. 1, p. 18-26, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2014.10.019. Acesso em: 10 jan. 2026. -
APA
Ruff, P., Ferry, D. R., Lakomỳ, R., McWalter, G., Van Hazel, G. A., Hoff, P. M., et al. (2015). Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, 51( 1), 18-26. doi:10.1016/j.ejca.2014.10.019 -
NLM
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2026 jan. 10 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019 -
Vancouver
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2026 jan. 10 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019 - Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community
- Immune-mediated pancytopenia induced by oxaliplatin: a case report
- A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers
- Palliative chemotherapy in patients with malignant bowel obstruction
- Is surgery always necessary in rectal cancer?
- Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database
- Pneumonite induzida por taxanos: relato de três casos e revisão da literatura
- O câncer no envelhecimento
- "É fundamental ter compaixão ao tratar um paciente com câncer" [Entrevista]
- Estudo epidemiológico de pacientes com adenocarcinoma colorretal submetidos à ressecção do primário: descrição de 212 pacientes operados no Instituto do Câncer do Estado de São Paulo - ICESP
Informações sobre o DOI: 10.1016/j.ejca.2014.10.019 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
